MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/mrm.29746

Медицинская библиотека · Magnetic resonance in medicine · 2023

Semi-solid MT and APTw CEST-MRI predict clinical outcome of patients with glioma early after radiotherapy.

Kroh Florian, von Knebel Doeberitz Nikolaus, Breitling Johannes, Maksimovic Srdjan, König Laila, Adeberg Sebastian, Scherer Moritz, Unterberg Andreas, Bendszus Martin, Wick Wolfgang, Bachert Peter, Debus Jürgen, Ladd Mark E, Schlemmer Heinz-Peter, Korzowski Andreas, Goerke Steffen, Paech Daniel

Клиническое исследованиеСтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

PURPOSE: The purpose of this study was to compare the potential of asymmetry-based (APTwasym ), Lorentzian-fit-based (PeakAreaAPT and MTconst ), and relaxation-compensated (MTRRex APT and MTRRex MT) CEST contrasts of the amide proton transfer (APT) and semi-solid magnetization transfer (ssMT) for early response assessment and prediction of progression-free survival (PFS) in patients with glioma.

METHODS

Seventy-two study participants underwent CEST-MRI at 3T from July 2018 to December 2021 in a prospective clinical trial four to 6 wk after the completion of radiotherapy for diffuse glioma. Tumor segmentations were performed on T2w -FLAIR and contrast-enhanced T1w images. Therapy response assessment and determination of PFS were performed according to response assessment in neuro oncology (RANO) criteria using clinical follow-up data with a median observation time of 9.2 mo (range, 1.6-40.8) and compared to CEST MRI metrics. Statistical testing included receiver operating characteristic analyses, Mann-Whitney-U-test, Kaplan-Meier analyses, and logrank-test.

RESULTS

MTconst (AUC = 0.79, p < 0.01) showed a stronger association with RANO response assessment compared to PeakAreaAPT (AUC = 0.71, p = 0.02) and MTRRex MT (AUC = 0.71, p = 0.02), and enabled differentiation of participants with pseudoprogression (n = 8) from those with true progression (AUC = 0.79, p = 0.02). Furthermore, MTconst (HR = 3.04, p = 0.01), PeakAreaAPT (HR = 0.39, p = 0.03), and APTwasym (HR = 2.63, p = 0.02) were associated with PFS. MTRRex APT was not associated with any outcome.

CONCLUSION

MTconst , PeakAreaAPT, and APTwasym imaging predict clinical outcome by means of progression-free survival. Furthermore, MTconst enables differentiation of radiation-induced pseudoprogression from disease progression. Therefore, the assessed metrics may have synergistic potential for supporting clinical decision making during follow-up of patients with glioma.

Для цитирования: Kroh Florian, von Knebel Doeberitz Nikolaus, Breitling Johannes, Maksimovic Srdjan, König Laila, Adeberg Sebastian, Scherer Moritz, Unterberg Andreas, Bendszus Martin, Wick Wolfgang, Bachert Peter, Debus Jürgen, Ladd Mark E, Schlemmer Heinz-Peter, Korzowski Andreas, Goerke Steffen, Paech Daniel. Semi-solid MT and APTw CEST-MRI predict clinical outcome of patients with glioma early after radiotherapy.. Magnetic resonance in medicine. 2023. DOI: 10.1002/mrm.29746.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.